StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
INVA

Innoviva, Inc.

INVA Nasdaq Pharmaceutical Preparations EDGAR ↗
$20.77
-0.20 -0.95%

Key statistics

from XBRL data in SEC filings
Market cap
$1.53B
Revenue (TTM)
$421M
Net income (TTM)
$504M
EPS (TTM)
$6.26
P/E ratio
3.3
Dividend yield
Free cash flow
$196M
Cash
$603M
Total assets
$1.84B
Gross margin
73.7%
52-week range
$16.52 – $25.15

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Director or officer change May 18, 2026 10-Q Quarter ended 2026-03-31 May 6, 2026 8-K Results of operations (earnings release) May 6, 2026 8-K Shareholder vote results May 4, 2026 10-K/A Fiscal year ended 2025-12-31 Mar 27, 2026 8-K Results of operations (earnings release) Feb 25, 2026 10-K Fiscal year ended 2025-12-31 Feb 25, 2026 10-Q Quarter ended 2025-09-30 Nov 5, 2025 8-K Results of operations (earnings release) Nov 5, 2025 10-Q Quarter ended 2025-06-30 Aug 6, 2025 8-K Results of operations (earnings release) Aug 6, 2025 8-K Shareholder vote results May 21, 2025 10-Q Quarter ended 2025-03-31 May 7, 2025 8-K Results of operations (earnings release) May 7, 2025 10-K/A Fiscal year ended 2024-12-31 Mar 24, 2025 10-K Fiscal year ended 2024-12-31 Feb 26, 2025 8-K Results of operations (earnings release) Feb 26, 2025 10-Q Quarter ended 2024-09-30 Nov 6, 2024 8-K Results of operations (earnings release) Nov 6, 2024 10-Q Quarter ended 2024-06-30 Jul 31, 2024 8-K Results of operations (earnings release) Jul 31, 2024 8-K Shareholder vote results Jun 20, 2024 8-K Regulation FD disclosure May 13, 2024 10-Q Quarter ended 2024-03-31 May 8, 2024 8-K Results of operations (earnings release) May 8, 2024 8-K Director or officer change Apr 30, 2024 10-K/A Fiscal year ended 2023-12-31 Mar 22, 2024 10-K/A Fiscal year ended 2023-12-31 Mar 5, 2024 10-K Fiscal year ended 2023-12-31 Feb 29, 2024 8-K Results of operations (earnings release) Feb 29, 2024 8-K Regulation FD disclosure Nov 6, 2023 10-Q Quarter ended 2023-09-30 Nov 1, 2023 8-K Results of operations (earnings release) Nov 1, 2023 8-K Director or officer change; Regulation FD disclosure Aug 25, 2023 8-K Delisting notice or listing-rule failure Aug 7, 2023 10-Q Quarter ended 2023-06-30 Aug 2, 2023 8-K Results of operations (earnings release) Aug 2, 2023 8-K Director or officer change; Regulation FD disclosure Jul 11, 2023 8-K Regulation FD disclosure May 24, 2023 8-K Shareholder vote results May 24, 2023